Clinical stage in Wakefield, Massachusetts

Innovation Pharmaceuticals Inc., located at 301 Edgewater Place in Wakefield, Massachusetts, is a health and pharmacy institution that also serves as a store for innovative medical products. One of their key products, Brilacidin, is known for its broad-spectrum antimicrobial properties and is being developed as a potential treatment for the debilitating side-effects of chemoradiation. Brilacidin is a small molecule mimetic of defensins, with Fast Track designation for its anti-inflammatory and antimicrobial properties. The institution is also working on a novel image-guided surgical laser platform for the treatment of cancer and epilepsy. As a publicly traded clinical stage biopharmaceutical company, Innovation Pharmaceuticals is dedicated to developing new therapies to address unmet medical needs, and is actively seeking out new investment opportunities to diversify its portfolio.